Baxalta
Industry / private company
Location:
,
United States (USA) (US)
ISNI: -
ROR: https://ror.org/040fqas51
Show on Map:
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies (2016)
Borte M, Krivan G, Derfalvi B, Marodi L, Harrer T, Jolles S, Bourgeois C, et al.
Journal article